Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats.
Journal
Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
22
02
2018
accepted:
20
06
2018
revised:
05
06
2018
pubmed:
16
8
2018
medline:
10
3
2021
entrez:
16
8
2018
Statut:
ppublish
Résumé
Despite the advances in pharmacological therapies, only the half of depressed patients respond to currently available treatment. Thus, the need for further investigation and development of effective therapies, especially those designed for treatment-resistant depression, has been sorely needed. Although antidepressant effects of mesenchymal stem cells (MSCs) have been reported, the potential benefit of this cell therapy on treatment-resistant depression is unknown. Cell encapsulation may enhance the survival rate of grafted cells, but the therapeutic effects and mechanisms mediating encapsulation of MSCs remain unexplored. Here, we showed that encapsulation enhanced the antidepressant effects of MSCs by attenuating depressive-like behavior of Wistar Kyoto (WKY) rats, which are considered as a promising animal model of treatment-resistant depression. The implantation of encapsulated MSCs (eMSCs) into the lateral ventricle counteracted depressive-like behavior and enhanced the endogenous neurogenesis in the subventricular zone (SVZ) and the dentate gyrus (DG) of the hippocampus, whereas the implantation of MSCs without encapsulation or the implantation of eMSCs into the striatum did not show such ameliorative effects. eMSCs displayed robust and stable secretion of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor, fibroblast growth factor-2, and ciliary neurotrophic factor (CNTF), and the implantation of eMSCs into the lateral ventricle activated relevant pathways associated with these growth factors. Additionally, eMSCs upregulated intrinsic expression of VEGF and CNTF and their receptors. This study suggests that the implantation of eMSCs into the lateral ventricle exerted antidepressant effects likely acting via neurogenic pathways, supporting their utility for depression treatment.
Identifiants
pubmed: 30108315
doi: 10.1038/s41380-018-0208-0
pii: 10.1038/s41380-018-0208-0
doi:
Substances chimiques
Antidepressive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1202-1214Commentaires et corrections
Type : CommentIn
Références
Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894–902.
pubmed: 2721780
pmcid: 2721780
doi: 10.1038/nature07455
Thornicroft G, Chatterji S, Evans-Lacko S, Gruber M, Sampson N, Aguilar-Gaxiola S, et al. Undertreatment of people with major depressive disorder in 21 countries. Br J Psychiatry. 2017;210:119–24.
pubmed: 27908899
pmcid: 5288082
doi: 10.1192/bjp.bp.116.188078
Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17.
doi: 10.1176/ajp.2006.163.11.1905
Willner P, Belzung C. Treatment-resistant depression: are animal models of depression fit for purpose? Psychopharmacology. 2015;232:3473–95.
pubmed: 26289353
doi: 10.1007/s00213-015-4034-7
Willner P, Scheel-Kruger J, Belzung C. Resistance to antidepressant drugs: the case for a more predisposition-based and less hippocampocentric research paradigm. Behav Pharmacol. 2014;25:352–71.
pubmed: 25083567
doi: 10.1097/FBP.0000000000000066
Kin K, Yasuhara T, Kameda M, Agari T, Sasaki T, Morimoto J, et al. Hippocampal neurogenesis of Wistar Kyoto rats is congenitally impaired and correlated with stress resistance. Behav Brain Res. 2017;329:148–56.
pubmed: 28465137
doi: 10.1016/j.bbr.2017.04.046
Pare WP. Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiol Behav. 1994;55:433–9.
pubmed: 8190758
doi: 10.1016/0031-9384(94)90097-3
Nam H, Clinton SM, Jackson NL, Kerman IA. Learned helplessness and social avoidance in the Wistar-Kyoto rat. Front Behav Neurosci. 2014;8:109.
pubmed: 24744709
pmcid: 3978372
doi: 10.3389/fnbeh.2014.00109
Rittenhouse PA, Lopez-Rubalcava C, Stanwood GD, Lucki I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology. 2002;27:303–18.
pubmed: 11818168
doi: 10.1016/S0306-4530(01)00052-X
Lopez-Rubalcava C, Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology. 2000;22:191–9.
pubmed: 10649831
doi: 10.1016/S0893-133X(99)00100-1
Will CC, Aird F, Redei EE. Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants. Mol Psychiatry. 2003;8:925–32.
pubmed: 14593430
doi: 10.1038/sj.mp.4001345
Tejani-Butt S, Kluczynski J, Pare WP. Strain-dependent modification of behavior following antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:7–14.
pubmed: 12551720
doi: 10.1016/S0278-5846(02)00308-1
Glavaski-Joksimovic A, Bohn MC. Mesenchymal stem cells and neuroregeneration in Parkinson’s disease. Exp Neurol. 2013;247:25–38.
pubmed: 23542820
doi: 10.1016/j.expneurol.2013.03.016
Karussis D, Kassis I, Kurkalli BG, Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci. 2008;265:131–5.
pubmed: 17610906
doi: 10.1016/j.jns.2007.05.005
Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009;8:491–500.
pubmed: 19375666
pmcid: 2727708
doi: 10.1016/S1474-4422(09)70061-4
Coquery N, Blesch A, Stroh A, Fernandez-Klett F, Klein J, Winter C, et al. Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity. Cytotherapy. 2012;14:1041–53.
pubmed: 22762522
doi: 10.3109/14653249.2012.694418
Tfilin M, Sudai E, Merenlender A, Gispan I, Yadid G, Turgeman G. Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol Psychiatry. 2010;15:1164–75.
pubmed: 19859069
doi: 10.1038/mp.2009.110
Overstreet DH, Wegener G. The flinders sensitive line rat model of depression--25 years and still producing. Pharmacol Rev. 2013;65:143–55.
pubmed: 23319547
doi: 10.1124/pr.111.005397
Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, et al. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson’s disease. Eur J Neurosci. 2004;19:1494–504.
pubmed: 15066146
doi: 10.1111/j.1460-9568.2004.03254.x
Yano A, Shingo T, Takeuchi A, Yasuhara T, Kobayashi K, Takahashi K, et al. Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg. 2005;103:104–14.
pubmed: 16121981
doi: 10.3171/jns.2005.103.1.0104
Kuramoto S, Yasuhara T, Agari T, Kondo A, Jing M, Kikuchi Y, et al. BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats. Brain Res. 2011;1368:281–9.
pubmed: 20971090
doi: 10.1016/j.brainres.2010.10.054
Paul G, Anisimov SV. The secretome of mesenchymal stem cells: potential implications for neuroregeneration. Biochimie. 2013;95:2246–56.
pubmed: 23871834
doi: 10.1016/j.biochi.2013.07.013
Wang F, Yasuhara T, Shingo T, Kameda M, Tajiri N, Yuan WJ, et al. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci. 2010;11:52.
pubmed: 20420688
pmcid: 2873592
doi: 10.1186/1471-2202-11-52
Yasuhara T, Hara K, Maki M, Matsukawa N, Fujino H, Date I, et al. Lack of exercise, via hindlimb suspension, impedes endogenous neurogenesis. Neuroscience. 2007;149:182–91.
pubmed: 17869433
doi: 10.1016/j.neuroscience.2007.07.045
Baldauf K, Reymann KG. Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia. Brain Res. 2005;1056:158–67.
pubmed: 16125154
doi: 10.1016/j.brainres.2005.07.035
Morimoto J, Yasuhara T, Kameda M, Umakoshi M, Kin I, Kuwahara K, et al. Electrical stimulation enhances migratory ability of transplanted bone marrow stromal cells in a rodent ischemic stroke model. Cell Physiol Biochem. 2018;46:57–68.
pubmed: 29587284
doi: 10.1159/000488409
Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000;20:9104–10.
pubmed: 11124987
pmcid: 6773038
doi: 10.1523/JNEUROSCI.20-24-09104.2000
Liu N, Chen R, Du H, Wang J, Zhang Y, Wen J. Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell Mol Immunol. 2009;6:207–13.
pubmed: 19567204
pmcid: 4003064
doi: 10.1038/cmi.2009.28
Long Q, Li J, Luo Q, Hei Y, Wang K, Tian Y, et al. MRI tracking of bone marrow mesenchymal stem cells labeled with ultra-small superparamagnetic iron oxide nanoparticles in a rat model of temporal lobe epilepsy. Neurosci Lett. 2015;606:30–35.
pubmed: 26318841
doi: 10.1016/j.neulet.2015.08.040
Ruzicka J, Kulijewicz-Nawrot M, Rodrigez-Arellano JJ, Jendelova P, Sykova E. Mesenchymal stem cells preserve working memory in the 3xTg-AD mouse model of Alzheimer’s disease. Int J Mol Sci. 2016;17:152.
pmcid: 4783886
doi: 10.3390/ijms17020152
Date I, Ohmoto T, Imaoka T, Ono T, Hammang JP, Francis J, et al. Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. J Neurosurg. 1996;84:1006–12.
pubmed: 8847564
doi: 10.3171/jns.1996.84.6.1006
Krishnan V, Nestler EJ. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry. 2010;167:1305–20.
pubmed: 20843874
pmcid: 3031089
doi: 10.1176/appi.ajp.2009.10030434
Shwartz A, Betzer O, Kronfeld N, Kazimirsky G, Cazacu S, Finniss S, et al. Therapeutic effect of astroglia-like mesenchymal stem cells expressing glutamate transporter in a genetic rat model of depression. Theranostics. 2017;7:2690–703.
pubmed: 28819456
pmcid: 5558562
doi: 10.7150/thno.18914
Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci. 2005;255:381–6.
pubmed: 15809771
doi: 10.1007/s00406-005-0578-6
Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry. 2005;57:1068–72.
pubmed: 15860348
doi: 10.1016/j.biopsych.2005.01.008
Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry. 2004;161:598–607.
pubmed: 15056502
doi: 10.1176/appi.ajp.161.4.598
Gomez-Pinilla F, Dao L, Choi J, Ryba EA. Diazepam induces FGF-2 mRNA in the hippocampus and striatum. Brain Res Bull. 2000;53:283–9.
pubmed: 11113582
doi: 10.1016/S0361-9230(00)00342-7
Maragnoli ME, Fumagalli F, Gennarelli M, Racagni G, Riva MA. Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol Psychiatry. 2004;55:1095–102.
pubmed: 15158429
doi: 10.1016/j.biopsych.2004.02.003
Mallei A, Shi B, Mocchetti I. Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol Pharmacol. 2002;61:1017–24.
pubmed: 11961119
doi: 10.1124/mol.61.5.1017
Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA. 2007;104:4647–52.
pubmed: 17360578
doi: 10.1073/pnas.0610282104
Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57:925–35.
pubmed: 11015810
doi: 10.1001/archpsyc.57.10.925
Turner CA, Clinton SM, Thompson RC, Watson SJ Jr, Akil H. Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals. Proc Natl Acad Sci USA. 2011;108:8021–5.
pubmed: 21518861
doi: 10.1073/pnas.1103732108
Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 2002;22:3251–61.
pubmed: 11943826
pmcid: 6757539
doi: 10.1523/JNEUROSCI.22-08-03251.2002
Turner CA, Gula EL, Taylor LP, Watson SJ, Akil H. Antidepressant-like effects of intracerebroventricular FGF2 in rats. Brain Res. 2008;1224:63–68.
pubmed: 18586016
pmcid: 2532793
doi: 10.1016/j.brainres.2008.05.088
Peruga I, Hartwig S, Merkler D, Thone J, Hovemann B, Juckel G, et al. Endogenous ciliary neurotrophic factor modulates anxiety and depressive-like behavior. Behav Brain Res. 2012;229:325–32.
pubmed: 22266927
doi: 10.1016/j.bbr.2012.01.020
Yang P, Arnold SA, Habas A, Hetman M, Hagg T. Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice. J Neurosci. 2008;28:2231–41.
pubmed: 18305256
pmcid: 6671859
doi: 10.1523/JNEUROSCI.3574-07.2008
Emsley JG, Hagg T. Endogenous and exogenous ciliary neurotrophic factor enhances forebrain neurogenesis in adult mice. Exp Neurol. 2003;183:298–310.
pubmed: 14552871
doi: 10.1016/S0014-4886(03)00129-8
Dutta R, McDonough J, Chang A, Swamy L, Siu A, Kidd GJ, et al. Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. Brain. 2007;130(Pt 10):2566–76.
pubmed: 17898009
doi: 10.1093/brain/awm206
Emerich DF, Thanos CG, Sanberg PR. Intraventricular implant of encapsulated CNTF-secreting fibroblasts ameliorates motor deficits in aged rats. Curr Aging Sci. 2008;1:105–11.
pubmed: 20021379
doi: 10.2174/1874609810801020105
Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The forced swim test as a model of depressive-like behavior. J Vis Exp. 2015;97:e52587.
Ichiba M, Nakajima K, Yamanaka Y, Kiuchi N, Hirano T. Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein. J Biol Chem. 1998;273:6132–8.
pubmed: 9497331
doi: 10.1074/jbc.273.11.6132
He F, Ge W, Martinowich K, Becker-Catania S, Coskun V, Zhu W, et al. A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat Neurosci. 2005;8:616–25.
pubmed: 15852015
pmcid: 4222251
doi: 10.1038/nn1440
Gutierrez-Fernandez M, Rodriguez-Frutos B, Ramos-Cejudo J, Teresa Vallejo-Cremades M, Fuentes B, Cerdan S, et al. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther. 2013;4:11.
pubmed: 23356495
pmcid: 3706777
doi: 10.1186/scrt159
Gutierrez-Fernandez M, Rodriguez-Frutos B, Alvarez-Grech J, Vallejo-Cremades MT, Exposito-Alcaide M, Merino J, et al. Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience. 2011;175:394–405.
pubmed: 21144885
doi: 10.1016/j.neuroscience.2010.11.054
Huang AH, Snyder BR, Cheng PH, Chan AW. Putative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice. Stem Cells. 2008;26:2654–63.
pubmed: 18687995
pmcid: 4416417
doi: 10.1634/stemcells.2008-0285
Ding J, He Z, Ruan J, Ma Z, Liu Y, Gong C, et al. Role of ciliary neurotrophic factor in the proliferation and differentiation of neural stem cells. J Alzheimer’s Dis. 2013;37:587–92.
doi: 10.3233/JAD-130527
Ceccariglia S, D’Altocolle A, Del Fa A, Silvestrini A, Barba M, Pizzolante F, et al. Increased expression of Aquaporin 4 in the rat hippocampus and cortex during trimethyltin-induced neurodegeneration. Neuroscience. 2014;274:273–88.
pubmed: 24912027
doi: 10.1016/j.neuroscience.2014.05.047
Greene J, Banasr M, Lee B, Warner-Schmidt J, Duman RS. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology. 2009;34:2459–68.
pubmed: 19553916
pmcid: 3694572
doi: 10.1038/npp.2009.68
Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31:761–77.
pubmed: 23735822
doi: 10.1159/000350094
Serafini G, Hayley S, Pompili M, Dwivedi Y, Brahmachari G, Girardi P, et al. Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets? CNS Neurol Disord Drug Targets. 2014;13:1708–21.
pubmed: 25470403
doi: 10.2174/1871527313666141130223723